Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1393-1408

  Lessard, A ^a   Grady, E F ^b   Bunnett, N W ^b,c   Pickel, V M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dopamine; midbrain; Parkinson disease; peptide receptors; schizophrenia; tachykinins

Indexed keywords

CATECHOLAMINE; GOLD; NEUROKININ 3 RECEPTOR; SILVER; TACHYKININ; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CELL LABELING; CELL MEMBRANE; CELL ULTRASTRUCTURE; CYTOPLASM; DENDRITE; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; GLIA CELL; IMMUNOGOLD LABELING; IMMUNOGOLD SILVER LABELING; IMMUNOREACTIVITY; LOCOMOTION; MALE; MOTIVATION; NERVE ENDING; NERVE EXCITABILITY; NERVE FIBER; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; SMOOTH ENDOPLASMIC RETICULUM; STRESS; SUBSTANTIA NIGRA; SYNAPSE; VENTRAL TEGMENTUM;

ANIMALS; CELL MEMBRANE; DENDRITES; DOPAMINE; INTRACELLULAR MEMBRANES; MALE; MICROSCOPY, IMMUNOELECTRON; NEUROGLIA; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-3; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TACHYKININS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 33846300683     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.10.058     Document Type: Article

References (89)

1. Adams M.M., Fink S.E., Shah R.A., Janssen W.G., Hayashi S., Milner T.A., McEwen B.S., and Morrison J.H. Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. J Neurosci 22 (2002) 3608-3614
2. Agnati L.F., Bjelke B., and Fuxe K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev 15 (1995) 33-45
3. Altier N., and Stewart J. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions. Behav Brain Res 89 (1997) 151-165
4. Altier N., and Stewart J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 285 (1998) 208-215
5. Altier N., and Stewart J. The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test. Physiol Behav 66 (1999) 717-721
6. Bannon M.J., and Whitty C.J. Neurokinin receptor gene expression in substantia nigra: localization, regulation, and potential physiological significance. Can J Physiol Pharmacol 73 (1995) 866-870
7. Bannon M.J., Elliott P.J., Alpert J.E., Goedert M., Iversen S.D., and Iversen L.L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature 306 (1983) 791-792
8. Bayer V.E., and Pickel V.M. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase-immunoreactivity in rat ventral tegmental area. Brain Res 559 (1991) 44-55
9. Beaujouan J.C., Torrens Y., Saffroy M., Kemel M.L., and Glowinski J. A 25 year adventure in the field of tachykinins. Peptides 25 (2004) 339-357
10. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 80 (2005) 1326-1338
11. Bishop C., and Walker P.D. Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat. Brain Res 1023 (2004) 126-133
12. Bolam J.P., and Smith Y. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res 529 (1990) 57-78
13. Carpentier C., and Baude A. Immunocytochemical localisation of NK3 receptors in the dorsal vagal complex of rat. Brain Res 734 (1996) 327-331
14. Carr D.B., and Sesack S.R. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38 (2000) 114-123
15. Chan J., Aoki C., and Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33 (1990) 113-127
16. Chan-Palay V., Jonsson G., and Palay S.L. Serotonin and substance P coexist in neurons of the rat's central nervous system. Proc Natl Acad Sci U S A 75 (1978) 1582-1586
17. Charara A., Smith Y., and Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364 (1996) 254-266
18. Chen L.W., Guan Z.L., and Ding Y.Q. Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat. Brain Res 780 (1998) 150-154
19. Contant C., Umbriaco D., Garcia S., Watkins K.C., and Descarries L. Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum. Neuroscience 71 (1996) 937-947
20. Culman J., and Unger T. Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol 73 (1995) 885-891
21. Deschamps K., and Couture R. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Br J Pharmacol 145 (2005) 712-727
22. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., and Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 364 (1996) 290-310
23. Elliott P.J., Mason G.S., Stephens-Smith M., and Hagan R.M. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides 19 (1991) 119-126
24. Friedman Y., Richter A., Raymond R., Loscher W., and Nobrega J.N. Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains. Neuroscience 112 (2002) 639-645
25. Furuta T., Koyano K., Tomioka R., Yanagawa Y., and Kaneko T. GABAergic basal forebrain neurons that express receptor for neurokinin B and send axons to the cerebral cortex. J Comp Neurol 473 (2004) 43-58
26. Fuxe K., Andersson K., Eneroth P., Jansson A., von Euler G., Tinner B., Bjelke B., and Agnati L.F. Neurochemical mechanisms underlying the neuroendocrine actions of nicotine: focus on the plasticity of central cholinergic nicotinic receptors. Prog Brain Res 79 (1989) 197-207
27. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460 (1988) 161-167
28. Gerfen C.R., and Wilson C.J. The basal ganglia (1996), Elsevier Science, New York
29. Gervais J., and Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 35 (2000) 281-291
30. Glowinski J., Kemel M.L., Desban M., Gauchy C., Lavielle S., Chassaing G., Beaujouan J.C., and Tremblay L. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Regul Pept 46 (1993) 124-128
31. Grady E.F., Baluk P., Bohm S., Gamp P.D., Wong H., Payan D.G., Ansel J., Portbury A.L., Furness J.B., McDonald D.M., and Bunnett N.W. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. J Neurosci 16 (1996) 6975-6986
32. Herve D., Pickel V.M., Joh T.H., and Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435 (1987) 71-83
33. Hoffman B.J., Hansson S.R., Mezey E., and Palkovits M. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19 (1998) 187-231
34. Hokfelt T., Ljungdahl A., Steinbusch H., Verhofstad A., Nilsson G., Brodin E., Pernow B., and Goldstein M. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience 3 (1978) 517-538
35. Humpel C., and Saria A. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Neurosci Lett 157 (1993) 223-226
36. Humpel C., Saria A., and Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur J Pharmacol 195 (1991) 107-114
37. Hutson P.H., Patel S., Jay M.T., and Barton C.L. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist. Eur J Pharmacol 484 (2004) 57-64
38. Iribe Y., Moore K., Pang K.C., and Tepper J.M. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro. J Neurophysiol 82 (1999) 925-933
39. Jessell T.M. Substance P release from the rat substantia nigra. Brain Res 151 (1978) 469-478
40. Kachidian P., Poulat P., Marlier L., and Privat A. Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat. J Neurosci Res 30 (1991) 521-530
41. Kanazawa I., Emson P.C., and Cuello A.C. Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain. Brain Res 119 (1977) 447-453
42. Knott C., Stern G., and Wilkin G.P. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16 (2000) 724-739
43. Langlois X., Wintmolders C., te Riele P., Leysen J.E., and Jurzak M. Detailed distribution of neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study. Neuropharmacology 40 (2001) 242-253
44. Leranth C., and Pickel V.M. Electron microscopic pre-embedding double immunostaining methods. In: Heimer L., and Zaborszky L. (Eds). Tract tracing methods 2, recent progress (1989), Plenum, New York 129-172
45. Lessard A., and Couture R. Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br J Pharmacol 134 (2001) 1749-1759
46. Lessard A., and Pickel V.M. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Neuroscience 135 (2005) 1309-1323
47. Lisoprawski A., Blanc G., and Glowinski J. Activation by stress of the habenulo-interpeduncular substance P neurons in the rat. Neurosci Lett 25 (1981) 47-51
48. Liu R., Ding Y., and Aghajanian G.K. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 27 (2002) 329-340
49. Lu X.Y., Ghasemzadeh M.B., and Kalivas P.W. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82 (1998) 767-780
50. Maggi C.A., Patacchini R., Rovero P., and Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol 13 (1993) 23-93
51. Mahalik T.J. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study. Synapse 2 (1988) 508-515
52. Mantyh P.W., Gates T., Mantyh C.R., and Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 9 (1989) 258-279
53. Marco N., Thirion A., Mons G., Bougault I., Le Fur G., Soubrie P., and Steinberg R. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides 32 (1998) 481-488
54. Massi M., Panocka I., and de Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 21 (2000) 1597-1609
55. Matute C., Domercq M., and Sanchez-Gomez M.V. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53 (2006) 212-224
56. Melis M.R., and Gale K. Evidence that nigral substance P controls the activity of the nigrotectal GABAergic pathway. Brain Res 295 (1984) 387-393
57. Mendez I., Elisevich K., and Flumerfelt B. Substance P synaptic interactions with GABAergic and dopaminergic neurons in rat substantia nigra: an ultrastructural double-labeling immunocytochemical study. Brain Res Bull 28 (1992) 557-563
58. Nalivaiko E., Michaud J.C., Soubrie P., Le Fur G., and Feltz P. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 78 (1997) 745-757
59. Overton P., Elliott P.J., Hagan R.M., and Clark D. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur J Pharmacol 213 (1992) 165-166
60. Oyamada H., Takatsuji K., Senba E., Mantyh P.W., and Tohyama M. Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina. Brain Res Dev Brain Res 117 (1999) 59-70
61. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, Toronto
62. Peters A., Palay S.L., and Webster H.D. The fine structure of the nervous system (1991), Oxford University Press, New York
63. Pickel V.M., Joh T.H., Chan J., and Beaudet A. Serotoninergic terminals: ultrastructure and synaptic interaction with catecholamine-containing neurons in the medial nuclei of the solitary tracts. J Comp Neurol 225 (1984) 291-301
64. Pickel V.M., Joh T.H., Field P.M., Becker C.G., and Reis D.J. Cellular localization of tyrosine hydroxylase by immunohistochemistry. J Histochem Cytochem 23 (1975) 1-12
65. Regoli D., Boudon A., and Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46 (1994) 551-599
66. Ribak C.E., Vaughn J.E., Saito K., Barber R., and Roberts E. Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Brain Res 116 (1976) 287-298
67. Rice M.E. Distinct regional differences in dopamine-mediated volume transmission. Prog Brain Res 125 (2000) 277-290
68. Schmidlin F., Dery O., Bunnett N.W., and Grady E.F. Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors. Proc Natl Acad Sci U S A 99 (2002) 3324-3329
69. Seabrook G.R., Bowery B.J., and Hill R.G. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur J Pharmacol 273 (1995) 113-119
70. Seybold V.S., Grkovic I., Portbury A.L., Ding Y.Q., Shigemoto R., Mizuno N., Furness J.B., and Southwell B.R. Relationship of NK3 receptor-immunoreactivity to subpopulations of neurons in rat spinal cord. J Comp Neurol 381 (1997) 439-448
71. Shughrue P.J., Lane M.V., and Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 372 (1996) 395-414
72. Smith I.D., and Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12 (1992) 287-303
73. Somogyi P., Priestley J.V., Cuello A.C., Smith A.D., and Bolam J.P. Synaptic connections of substance P-immunoreactive nerve terminals in the substantia nigra of the rat. A correlated light- and electron-microscopic study. Cell Tissue Res 223 (1982) 469-486
74. Soubrie P., Reisine T.D., and Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 13 (1984) 605-625
75. Stacey A.E., Woodhall G.L., and Jones R.S. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses. Eur J Neurosci 16 (2002) 1896-1906
76. Steffensen S.C., Svingos A.L., Pickel V.M., and Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 18 (1998) 8003-8015
77. Steinbusch H., and Tilders F.J.H. Immunohistochemical techniques for light-microscopical localization of dopamine, noradrenaline, serotonin and histamine in the central nervous system. In: Steinbusch H. (Ed). Monoaminergic neurons: light microscopy and ultrastructure (1987), Wiley, New York 125-166
78. Stoessl A.J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res 646 (1994) 13-18
79. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9 (1982) 321-353
80. Swanson L.W., and Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163 (1975) 467-505
81. Tamiya R., Hanada M., Kawai Y., Inagaki S., and Takagi H. Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci Lett 110 (1990) 11-15
82. Tooney P.A., Au G.G., and Chahl L.A. Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain. Clin Exp Pharmacol Physiol 27 (2000) 947-949
83. Tremblay L., Kemel M.L., Desban M., Gauchy C., and Glowinski J. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc Natl Acad Sci U S A 89 (1992) 11214-11218
84. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63 (2001) 241-320
85. Van Bockstaele E.J., and Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res 682 (1995) 215-221
86. Van Bockstaele E.J., Cestari D.M., and Pickel V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res 647 (1994) 307-322
87. Whitty C.J., Walker P.D., Goebel D.J., Poosch M.S., and Bannon M.J. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience 64 (1995) 419-425
88. Zerari F., Karpitskiy V., Krause J., Descarries L., and Couture R. Immunoelectron microscopic localization of NK-3 receptor in the rat spinal cord. Neuroreport 8 (1997) 2661-2664
89. Zoli M., Torri C., Ferrari R., Jansson A., Zini I., Fuxe K., and Agnati L.F. The emergence of the volume transmission concept. Brain Res Brain Res Rev 26 (1998) 136-147